247 related articles for article (PubMed ID: 34335697)
1. Comprehensive Analysis of the Value of SMYD Family Members in the Prognosis and Immune Infiltration of Malignant Digestive System Tumors.
Liu D; Wang X; Shi E; Wang L; Nie M; Li L; Jiang Q; Kong P; Shi S; Wang C; Yan S; Qin Z; Zhao S
Front Genet; 2021; 12():699910. PubMed ID: 34335697
[TBL] [Abstract][Full Text] [Related]
2. SMYD Family Members Serve as Potential Prognostic Markers and Correlate with Immune Infiltrates in Gastric Cancer.
Liu D; Liu M; Wang W; Li X; Shi E; Zhang C; Wang Y; Zhang Y; Wang L; Wang X
J Oncol; 2023; 2023():6032864. PubMed ID: 36816359
[TBL] [Abstract][Full Text] [Related]
3. Expression patterns and the prognostic value of the SMYD family members in human breast carcinoma using integrative bioinformatics analysis.
Song J; Liu Y; Chen Q; Yang J; Jiang Z; Zhang H; Liu Z; Jin B
Oncol Lett; 2019 Apr; 17(4):3851-3861. PubMed ID: 30930987
[TBL] [Abstract][Full Text] [Related]
4. Targeting Epigenetic Changes Mediated by Members of the SMYD Family of Lysine Methyltransferases.
Padilla A; Manganaro JF; Huesgen L; Roess DA; Brown MA; Crans DC
Molecules; 2023 Feb; 28(4):. PubMed ID: 36838987
[TBL] [Abstract][Full Text] [Related]
5. The prognostic and antitumor roles of key genes of ferroptosis in liver hepatocellular cancer and stomach adenocarcinoma.
Pei W; Jiang M; Liu H; Song J; Hu J
Cancer Biomark; 2024; 39(4):335-347. PubMed ID: 38393890
[TBL] [Abstract][Full Text] [Related]
6. Integrative Multi-Omics Analysis of Identified Ferroptosis-Marker RPL8 as a Candidate Oncogene Correlates with Poor Prognosis and Immune Infiltration in Liver Cancer.
Fan S; Zhang S; Kong D; Wang H; Shi Y; Wang Z; Zheng H
Comb Chem High Throughput Screen; 2023; 26(7):1298-1310. PubMed ID: 36017842
[TBL] [Abstract][Full Text] [Related]
7. Identification and Validation of Chromobox Family Members as Potential Prognostic Biomarkers and Therapeutic Targets for Human Esophageal Cancer.
Fang X; Wang J; Chen J; Zhuang M; Huang T; Chen Z; Huang Y; Zheng B; Wang X
Front Genet; 2022; 13():851390. PubMed ID: 35464847
[No Abstract] [Full Text] [Related]
8. The SMYD family proteins in immunology: An update of their obvious and non-obvious relations with the immune system.
Rubio-Tomás T
Heliyon; 2021 Jun; 7(6):e07387. PubMed ID: 34235289
[TBL] [Abstract][Full Text] [Related]
9. SMYD proteins: key regulators in skeletal and cardiac muscle development and function.
Du SJ; Tan X; Zhang J
Anat Rec (Hoboken); 2014 Sep; 297(9):1650-62. PubMed ID: 25125178
[TBL] [Abstract][Full Text] [Related]
10. The Smyd Family of Methyltransferases: Role in Cardiac and Skeletal Muscle Physiology and Pathology.
Tracy C; Warren JS; Szulik M; Wang L; Garcia J; Makaju A; Russell K; Miller M; Franklin S
Curr Opin Physiol; 2018 Feb; 1():140-152. PubMed ID: 29435515
[TBL] [Abstract][Full Text] [Related]
11. Functions of SMYD proteins in biological processes: What do we know? An updated review.
Rueda-Robles A; Audano M; Álvarez-Mercado AI; Rubio-Tomás T
Arch Biochem Biophys; 2021 Nov; 712():109040. PubMed ID: 34555372
[TBL] [Abstract][Full Text] [Related]
12. Computational approach for assessing the involvement of SMYD2 protein in human cancers using TCGA data.
Yadav AK; Singh TR
J Genet Eng Biotechnol; 2023 Nov; 21(1):122. PubMed ID: 37971632
[TBL] [Abstract][Full Text] [Related]
13. Structure of human lysine methyltransferase Smyd2 reveals insights into the substrate divergence in Smyd proteins.
Xu S; Zhong C; Zhang T; Ding J
J Mol Cell Biol; 2011 Oct; 3(5):293-300. PubMed ID: 21724641
[TBL] [Abstract][Full Text] [Related]
14. Evolutionary History of the Smyd Gene Family in Metazoans: A Framework to Identify the Orthologs of Human Smyd Genes in Drosophila and Other Animal Species.
Calpena E; Palau F; Espinós C; Galindo MI
PLoS One; 2015; 10(7):e0134106. PubMed ID: 26230726
[TBL] [Abstract][Full Text] [Related]
15. Pan-cancer analysis from multi-omics data reveals AAMP as an unfavourable prognostic marker.
Wang Y; Liu T; Zhang K; Huang RH; Jiang L
Eur J Med Res; 2023 Jul; 28(1):258. PubMed ID: 37501187
[TBL] [Abstract][Full Text] [Related]
16. Proteomic analyses of the SMYD family interactomes identify HSP90 as a novel target for SMYD2.
Abu-Farha M; Lanouette S; Elisma F; Tremblay V; Butson J; Figeys D; Couture JF
J Mol Cell Biol; 2011 Oct; 3(5):301-8. PubMed ID: 22028380
[TBL] [Abstract][Full Text] [Related]
17. smyd1 and smyd2 are expressed in muscle tissue in Xenopus laevis.
Kawamura S; Yoshigai E; Kuhara S; Tashiro K
Cytotechnology; 2008 Jun; 57(2):161-8. PubMed ID: 19003161
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive Analysis and Identification of Prognostic Biomarkers and Therapeutic Targets Among FAM83 Family Members for Gastric Cancer.
Zhang T; Lai S; Cai Y; Huang Z; Li Y; Chen S; Zhang Z; Ye Z; Lai X; Zhai E; Cai S; Chen J
Front Cell Dev Biol; 2021; 9():719613. PubMed ID: 34869310
[No Abstract] [Full Text] [Related]
19. Systematic investigation of the clinical significance and prognostic value of the CBXs in esophageal cancer.
Hou J; Yang Y; Gao H; Ouyang T; Liu Q; Ding R; Kan H
Medicine (Baltimore); 2022 Oct; 101(40):e30888. PubMed ID: 36221371
[TBL] [Abstract][Full Text] [Related]
20. Residual expression of SMYD2 and SMYD3 is associated with the acquisition of complex karyotype in chronic lymphocytic leukemia.
Oliveira-Santos W; Rabello DA; Lucena-Araujo AR; de Oliveira FM; Rego EM; Pittella Silva F; Saldanha-Araujo F
Tumour Biol; 2016 Jul; 37(7):9473-81. PubMed ID: 26790435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
